Satoru Maruyama

1.5k total citations
70 papers, 989 citations indexed

About

Satoru Maruyama is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Urology. According to data from OpenAlex, Satoru Maruyama has authored 70 papers receiving a total of 989 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Pulmonary and Respiratory Medicine, 29 papers in Surgery and 12 papers in Urology. Recurrent topics in Satoru Maruyama's work include Bladder and Urothelial Cancer Treatments (28 papers), Urinary and Genital Oncology Studies (20 papers) and Renal cell carcinoma treatment (14 papers). Satoru Maruyama is often cited by papers focused on Bladder and Urothelial Cancer Treatments (28 papers), Urinary and Genital Oncology Studies (20 papers) and Renal cell carcinoma treatment (14 papers). Satoru Maruyama collaborates with scholars based in Japan, United Kingdom and Russia. Satoru Maruyama's co-authors include Nobuo Shinohara, Takashige Abe, Katsuya Nonomura, Ataru Sazawa, Naoto Miyajima, Toru Harabayashi, Shigetsugu Hatakeyama, Ryuji Matsumoto, Takahiro Osawa and Miyuki Bohgaki and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Satoru Maruyama

67 papers receiving 961 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Satoru Maruyama Japan 19 425 322 198 172 162 70 989
P.J. O’Sullivan United States 19 593 1.4× 355 1.1× 213 1.1× 107 0.6× 179 1.1× 54 1.1k
Christoph Wiesner Germany 21 441 1.0× 378 1.2× 373 1.9× 248 1.4× 225 1.4× 84 1.1k
Hristos Z. Kaimakliotis United States 20 893 2.1× 243 0.8× 229 1.2× 235 1.4× 246 1.5× 89 1.3k
Patricia Zondervan Netherlands 18 252 0.6× 438 1.4× 239 1.2× 47 0.3× 108 0.7× 78 974
Marcus Katoh Germany 24 424 1.0× 490 1.5× 72 0.4× 46 0.3× 49 0.3× 84 2.0k
Toshiyuki Okumura Japan 17 198 0.5× 574 1.8× 120 0.6× 22 0.1× 103 0.6× 58 1.2k
Michael D. Sapozink United States 22 145 0.3× 237 0.7× 76 0.4× 98 0.6× 102 0.6× 43 1.2k
Benjamin W. Fischer‐Valuck United States 20 222 0.5× 605 1.9× 96 0.5× 60 0.3× 187 1.2× 72 1.2k
Susanne Rogers Switzerland 18 191 0.4× 309 1.0× 236 1.2× 23 0.1× 291 1.8× 54 1.1k
Rony Avritscher United States 18 179 0.4× 291 0.9× 141 0.7× 17 0.1× 199 1.2× 75 1.0k

Countries citing papers authored by Satoru Maruyama

Since Specialization
Citations

This map shows the geographic impact of Satoru Maruyama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Satoru Maruyama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Satoru Maruyama more than expected).

Fields of papers citing papers by Satoru Maruyama

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Satoru Maruyama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Satoru Maruyama. The network helps show where Satoru Maruyama may publish in the future.

Co-authorship network of co-authors of Satoru Maruyama

This figure shows the co-authorship network connecting the top 25 collaborators of Satoru Maruyama. A scholar is included among the top collaborators of Satoru Maruyama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Satoru Maruyama. Satoru Maruyama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kita, Yuki, Katsuhiro Ito, Takeshi Sano, et al.. (2022). Immune‐related adverse events in urothelial cancer patients: Adjustment for immortal time bias. Cancer Science. 113(11). 3912–3921. 9 indexed citations
2.
Maruyama, Satoru, et al.. (2022). Identifying Early Predictive Markers for Immune-Related Adverse Events in Nivolumab-Treated Patients with Renal Cell Carcinoma and Gastric Cancer. Asian Pacific Journal of Cancer Prevention. 23(2). 695–701. 14 indexed citations
3.
Kikuchi, Hiroshi, Takahiro Osawa, Takashige Abe, et al.. (2022). Quality improvement in managing patients with non-muscle-invasive bladder cancer by introducing a surgical checklist for transurethral resection of bladder tumor. PLoS ONE. 17(10). e0276816–e0276816. 6 indexed citations
4.
Kato, Takuma, Hiromi Hirama, Koji Mitsuzuka, et al.. (2021). Reclassification prediction of first-year protocol biopsy on active surveillance of prostate cancer by p2PSA-related parameters: from PRIAS-JAPAN. Prostate Cancer and Prostatic Diseases. 25(4). 666–671. 5 indexed citations
5.
Tohi, Yoichiro, Takuma Kato, Masaki Nakamura, et al.. (2021). Deferred radical prostatectomy in patients who initially elected for active surveillance: a multi-institutional, prospective, observational cohort of the PRIAS-JAPAN study. International Journal of Clinical Oncology. 27(1). 194–201. 4 indexed citations
6.
Matsumoto, Ryuji, Takashige Abe, Keita Minami, et al.. (2020). Oncologic outcomes of laparoscopic radical nephroureterectomy in conjunction with template-based lymph node dissection: An extended follow-up study. Urologic Oncology Seminars and Original Investigations. 38(12). 933.e13–933.e18. 7 indexed citations
7.
Maruyama, Satoru, et al.. (2020). Optimization of Fluid Loading on Programmable Microfluidic Devices for Bio-protocol Execution. 550–555. 2 indexed citations
8.
Nishioka, Kentaro, Shinichi Shimizu, Nobuo Shinohara, et al.. (2017). Analysis of inter- and intra fractional partial bladder wall movement using implanted fiducial markers. Radiation Oncology. 12(1). 44–44. 10 indexed citations
9.
Abe, Takashige, Hiroshi Kikuchi, Ryuji Matsumoto, et al.. (2017). Perioperative morbidity and mortality of octogenarians treated by radical cystectomy—a multi-institutional retrospective study in Japan. Japanese Journal of Clinical Oncology. 47(8). 755–761. 8 indexed citations
10.
Abe, Takashige, Hiroshi Kikuchi, Keita Minami, et al.. (2016). Outcome of metastatic urothelial carcinoma treated by systemic chemotherapy: Prognostic factors based on real-world clinical practice in Japan. Urologic Oncology Seminars and Original Investigations. 35(2). 38.e1–38.e8. 19 indexed citations
11.
Matsumoto, Ryuji, Takashige Abe, Keita Minami, et al.. (2015). Prospective mapping of lymph node metastasis in Japanese patients undergoing radical cystectomy for bladder cancer: characteristics of micrometastasis. Japanese Journal of Clinical Oncology. 45(9). 874–880. 7 indexed citations
12.
Matsumoto, Ryuji, Nobuo Shinohara, Naoto Kuroda, et al.. (2015). Concurrent occurrence of renal cell carcinoma with rhabdoid features in a married couple: a case report. BMC Research Notes. 8(1). 3–3. 1 indexed citations
13.
Abe, Takashige, Ryuji Matsumoto, Takahiro Osawa, et al.. (2014). Outcome of Regional Lymphadenectomy in Accordance with Primary Tumor Location on Laparoscopic Nephroureterectomy for Urothelial Carcinoma of the Upper Urinary Tract: A Prospective Study. Journal of Endourology. 29(3). 304–309. 16 indexed citations
15.
Sugimoto, Mikio, Hiromi Hirama, Akito Yamaguchi, et al.. (2014). Should inclusion criteria for active surveillance for low-risk prostate cancer be more stringent? From an interim analysis of PRIAS-JAPAN. World Journal of Urology. 33(7). 981–987. 11 indexed citations
16.
Kamishima, Tamotsu, Kanako Kubota, Ichiro Yabe, et al.. (2010). Extramedullary plasmacytoma involving perirenal space accompanied by extramedullary hematopoiesis and amyloid deposition. Japanese Journal of Radiology. 28(4). 309–313. 3 indexed citations
17.
Shinohara, Nobuo, A Kumagai, Kazuhiro Kanagawa, et al.. (2009). Multicenter Phase II Trial of Combination Therapy with Meloxicam, a COX-2 Inhibitor, and Natural Interferon-  for Metastatic Renal Cell Carcinoma. Japanese Journal of Clinical Oncology. 39(11). 720–726. 23 indexed citations
18.
Nakajima, Ayako, Satoru Maruyama, Miyuki Bohgaki, et al.. (2007). Ligand-dependent transcription of estrogen receptor α is mediated by the ubiquitin ligase EFP. Biochemical and Biophysical Research Communications. 357(1). 245–251. 37 indexed citations
19.
Maruyama, Satoru, Naoto Miyajima, Miyuki Bohgaki, et al.. (2007). Ubiquitylation of ε-COP by PIRH2 and regulation of the secretion of PSA. Molecular and Cellular Biochemistry. 307(1-2). 73–82. 13 indexed citations
20.
Hashizume, T, et al.. (1964). [ESTIMATION OF BONE MARROW FROM RADIOGRAPHY OF X-RAY EXAMINATION].. PubMed. 24. 1087–93. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026